Unknown

Dataset Information

0

Bioactive-Tissue-Derived Nanocomposite Hydrogel for Permanent Arterial Embolization and Enhanced Vascular Healing.


ABSTRACT: Transcatheter embolization is a minimally invasive procedure that uses embolic agents to intentionally block diseased or injured blood vessels for therapeutic purposes. Embolic agents in clinical practice are limited by recanalization, risk of non-target embolization, failure in coagulopathic patients, high cost, and toxicity. Here, a decellularized cardiac extracellular matrix (ECM)-based nanocomposite hydrogel is developed to provide superior mechanical stability, catheter injectability, retrievability, antibacterial properties, and biological activity to prevent recanalization. The embolic efficacy of the shear-thinning ECM-based hydrogel is shown in a porcine survival model of embolization in the iliac artery and the renal artery. The ECM-based hydrogel promotes arterial vessel wall remodeling and a fibroinflammatory response while undergoing significant biodegradation such that only 25% of the embolic material remains at 14 days. With its unprecedented proregenerative, antibacterial properties coupled with favorable mechanical properties, and its superior performance in anticoagulated blood, the ECM-based hydrogel has the potential to be a next-generation biofunctional embolic agent that can successfully treat a wide range of vascular diseases.

SUBMITTER: Hu J 

PROVIDER: S-EPMC7491606 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC6562986 | biostudies-literature
| S-EPMC8652251 | biostudies-literature
| S-EPMC6684526 | biostudies-literature
| S-EPMC9277594 | biostudies-literature
| S-EPMC6332800 | biostudies-literature
| S-EPMC8141414 | biostudies-literature
| S-EPMC8151889 | biostudies-literature
| S-EPMC1903348 | biostudies-literature
| S-EPMC4189622 | biostudies-literature
| S-EPMC8079829 | biostudies-literature